Our Commitment to Safety and Transparency as We Study Our Investigational COVID-19 Vaccine Candidate
Learn More
Share
Mental health
On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
At the height of the outbreak in New York City, Dr. Ed Kuffner took a leave of absence from his job to volunteer at a Brooklyn hospital hard hit by the pandemic. He shares what the experience taught him about his own strengths—and ideas for coping during this unprecedented time.
Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.
From a $10 million pledge to UNICEF in support of health workers to promising news about a preventive HIV vaccine regimen, the company’s new 2018 Health for Humanity Report details how Johnson & Johnson is dedicated to creating a better future for everyone, everywhere.
A staggering 1 in 7 women suffer from perinatal mood disorders, which can begin as early as pregnancy. We take a look at how these scientists are working to find ways to help halt depression in moms at the most critical juncture: before it starts.
From scientists in research labs to CEOs at companies across the country, here's how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
Imade Nibokun Borha, 31, shares the raw truth about living with treatment-resistant depression—and the surprising silver lining she's found through her diagnosis.
From breakthrough work to eradicate some of the world's deadliest diseases to advancements in cutting-edge health technology, see just some of the ways Johnson & Johnson is working to help change the trajectory of health for humanity.
The company has secured a top ranking on the biennial report—which grades companies on their efforts to make medicine more accessible to those in low- and middle-income countries—for the fourth consecutive time.
Most people get health insurance on the job, but what about resilience training, emergency backup care for loved ones and financial coaching? These are just a few of the unique programs the company is proud to offer.
Fact: 60% of Americans live with at least one long-term health condition—and many of them face daily pain. We asked some of these very patients to share reality-tested ways they've learned to take control of their lives.
For World Bipolar Day, Michelle Dickinson shares her raw personal story—and how that struggle has inspired her to help others affected by mental illness.
With company leaders at the World Economic Forum in Davos this week, Johnson & Johnson's Chief Scientific Officer weighs in on the next great global healthcare challenge—and how we can all come together to help address it.
Shortly after Fernando Salinas took custody of 4-year-old Ilio, he discovered his son had AIDS. For World AIDS Day, we're sharing his powerful story of hope, perseverance and unconditional fatherly love.
It's a complicated illness, with no exact cause—but there is still a lot we understand now about depression, thanks to the work of dedicated scientists. For Depression Awareness Month, we look at the facts, common misconceptions and research that's underway.
